To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.
NCT03123653
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
118
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Peg IFN 2b
Sponsor
Institute of Liver and Biliary Sciences, India